Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed schedule of Meeting with Institutional shareholders/analysts as per attached Annexure A. Further, please note that no presentation will be made at the Meeting. The said intimation is available on the website of the Company at www.abbott.co.in
12-03-2021

Buy Abbott India; target of Rs 19425: Sharekhan

 Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 19425 in its research report dated February 09, 2021.
11-02-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper cuttings of the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2020 published in Business Standard (All Editions) and Loksatta on Wednesday, February 10, 2021. This is for your information and record. Kindly acknowledge receipt of the same.
10-02-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Re-Appointment Of Ms. Anisha Motwani (DIN: 06943493) As Independent Director For A Further Term Of 5 (Five) Years With Effect From April 25, 2021

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Board of Directors at its Meeting held today i.e. February 9, 2021 have approved the re-appointment of Ms. Anisha Motwani (DIN: 06943493) as an Independent Director for a further term of 5 (five) years with effect from April 25, 2021, subject to approval of the Shareholders of the Company at the ensuing Annual General Meeting. Additional details required under the Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A. We request you to kindly take the same on records.
09-02-2021

Abbott India Q3 net profit down 5% to Rs 177 crore

 The company had posted a net profit of Rs 186.69 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.
09-02-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended On December 31, 2020

 Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2020, approved by the Board of Directors at its Meeting held today i.e., Tuesday, February 9, 2021 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 1.30 pm and concluded at 3.00 pm. Kindly acknowledge the receipt of the same.
09-02-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed the copies of Public Notice published as per Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in Business Standard (All Editions) and Loksatta on Friday, January 29, 2021 in connection with the Meeting of the Board of Directors to be held on Tuesday, February 9, 2021. This is for your information and records.
29-01-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Board Meeting Intimation for Approving The Text Of Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended On December 31, 2020

 ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2020. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Thursday, December 31, 2020 to Thursday, February 11, 2021 (both days inclusive).
29-01-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation under Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
15-01-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Shareholding for the Period Ended December 31, 2020

 Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
11-01-2021
Next Page
Close

Let's Open Free Demat Account